Capitol Health (ASX:CAJ) - Hisse Senedi Fiyatı, Haberler ve Analizler

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

CAJ Stoklara Genel Bakış

Capitol Health Limited, Avustralya'daki sağlık hizmetleri pazarına tanısal görüntüleme yöntemleri ve ilgili hizmetler sunmaktadır.

Şirket hakkında

CAJ temel anali̇z
Kar Tanesi Skoru
Değerleme	0/6
Gelecekteki Büyüme	4/6
Geçmiş Performans	0/6
Finansal Sağlık	2/6
Temettüler	3/6

Ödüller

Kazançların yılda 69.22% oranında artması öngörülüyor

Risk Analizi

Yüksek borç seviyesine sahip

2.7% temettüsü kazançlar tarafından iyi karşılanmıyor

Capitol Health Limited Rakipler

Integral Diagnostics

ASX:IDX

AU$706.4m

Australian Clinical Labs

ASX:ACL

AU$748.9m

Healthia

ASX:HLA

AU$252.1m

SILK Laser Australia

ASX:SLA

AU$177.4m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Capitol Health
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	AU$0.37
52 Haftanın En Yüksek Seviyesi	AU$0.38
52 Haftanın En Düşük Seviyesi	AU$0.18
Beta	0.65
11 Aylık Değişim	15.63%
3 Aylık Değişim	19.35%
1 Yıllık Değişim	85.00%
33 Yıllık Değişim	-1.33%
5 Yıllık Değişim	57.45%
Halka arzdan bu yana değişim	39.62%

Son Haberler & Güncellemeler

Recent updates

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04

Hissedar Getirileri

	CAJ	AU Healthcare	AU Pazar
7D	2.8%	3.8%	1.1%
1Y	85.0%	-0.7%	17.9%

Getiri vs. Endüstri: CAJ geçen yıl % -0.7 oranında getiri sağlayan Australian Healthcare sektörünü aştı.

Getiri vs Piyasa: CAJ geçen yıl % 17.9 oranında getiri sağlayan Australian Piyasasını aştı.

Fiyat Oynaklığı

Is CAJ's price volatile compared to industry and market?
CAJ volatility
CAJ Average Weekly Movement	4.0%
Healthcare Industry Average Movement	5.1%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.6%
10% least volatile stocks in AU Market	3.6%

İstikrarlı Hisse Senedi Fiyatı: CAJ son 3 ayda önemli bir fiyat oynaklığı yaşamadı.

Zaman İçindeki Volatilite: CAJ 'nin haftalık oynaklığı ( 4% ) son bir yıldır istikrarlı seyretti.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2005	1,000	Justin Walter	www.capitolhealth.com.au

Capitol Health Limited, Avustralya'daki sağlık hizmetleri pazarına tanısal görüntüleme modaliteleri ve ilgili hizmetler sunmaktadır. Genel röntgen, manyetik rezonans görüntüleme, ultrason, mamografi, Doppler, ortopantomogram, ekokardiyografi, bilgisayarlı tomografi, BT anjiyografi, konik ışınlı BT, nükleer tıp, kemik dansitometrisi ve floroskopi dahil olmak üzere bir dizi tanısal görüntüleme hizmeti sunmaktadır. Victoria, Tazmanya, Batı Avustralya ve Güney Avustralya'da Capital Radiology markasının yanı sıra Imaging Olympic Park, Radiology Tasmania, Fowler Simmons Radiology, Womens' Imaging, Direct Radiology ve Future Medical Imaging Group markaları altında çeşitli klinikler işletmektedir.

Capitol Health Limited Temel Bilgiler Özeti

Capitol Health'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
CAJ temel i̇stati̇sti̇kler
Piyasa değeri	AU$394.26m
Kazançlar(TTM)	-AU$14.85m
Gelir(TTM)	AU$234.82m

1.7x

P/S Oranı

-26.5x

F/K Oranı

CAJ aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
CAJ gelir tablosu (TTM)
Gelir	AU$234.82m
Gelir Maliyeti	AU$178.96m
Brüt Kâr	AU$55.86m
Diğer Giderler	AU$70.71m
Kazançlar	-AU$14.85m

Son Raporlanan Kazançlar

Jun 30, 2024

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)	-0.014
Brüt Marj	23.79%
Net Kâr Marjı	-6.33%
Borç/Özkaynak Oranı	74.8%

CAJ uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

Temettüler

2.7%

Mevcut Temettü Verimi

-177%

Ödeme Oranı

CAJ Stoklara Genel Bakış

Ödüller

Risk Analizi

Capitol Health Limited Rakipler

ASX:IDX

AU$706.4m

ASX:ACL

AU$748.9m

ASX:HLA

AU$252.1m

ASX:SLA

AU$177.4m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Recent updates

Insufficient new directors

Capitol Health Limited, Annual General Meeting, Feb 28, 2025

Final dividend of AU$0.004 announced

Price target increased by 7.1% to AU$0.31

Full year 2024 earnings released: AU$0.014 loss per share (vs AU$0.011 loss in FY 2023)

Capitol Health Limited Provides Earnings Guidance for the Year 2025

Capitol Health Limited to Report Fiscal Year 2024 Results on Aug 22, 2024

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Calculating The Fair Value Of Capitol Health Limited (ASX:CAJ)

Now 21% undervalued after recent price drop

Now 21% undervalued

First half dividend of AU$0.005 announced

First half 2024 earnings released: EPS: AU$0.002 (vs AU$0.015 loss in 1H 2023)

New major risk - Financial position

Now 20% undervalued

Capitol Health Limited to Report First Half, 2024 Results on Feb 29, 2024

Capitol Health Limited Appoints Brendon Pentland as the Chief Financial Officer, Effective 1 April 2024

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Now 21% undervalued

Now 21% undervalued after recent price drop

Capitol Health Limited Announces the Resignation of Craig Bremner as Chief Financial Officer

Now 20% undervalued after recent price drop

Now 20% undervalued after recent price drop

Price target decreased by 9.8% to AU$0.28

Capitol Health Limited, Annual General Meeting, Nov 15, 2023

Full year 2023 earnings: EPS misses analyst expectations

Capitol Health Limited to Report Fiscal Year 2023 Results on Aug 24, 2023

Price target decreased by 9.6% to AU$0.33

Capitol Health Limited to Report First Half, 2023 Results on Feb 23, 2023

Now 21% undervalued

Now 21% undervalued

Capitol Health Limited (ASX:CAJ) completed the acquisition of Future Medical Imaging Group Pty Ltd.

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health Limited Declares Franked Dividend for the Six Months Ended June 30, 2022, Payable on October 21, 2022

Price target increased to AU$0.43

Capitol Health Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings: EPS misses analyst expectations

Capitol Health Limited Announces Dividend for the Six Months Ended June 30, 2022, Payable on 21 October, 2022

Consensus EPS estimates fall by 12%

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Capitol Health Limited Announces Dividend for the Six Months Ended December 31, 2021, Payable on April 1, 2022

Capitol Health Limited to Report First Half, 2022 Results on Feb 24, 2022

Full year 2021 earnings released: EPS AU$0.012 (vs AU$0.001 in FY 2020)

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Analysts increase EPS estimates to AU$0.012

First half 2021 earnings released: EPS AU$0.006 (vs AU$0.004 in 1H 2020)

Price target raised to AU$0.36

New 90-day high: AU$0.34

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Capitol Health Limited (ASX:CAJ) acquired Direct Radiology.

Capitol Health Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: AU$0.28

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?